![Chip Baird](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chip Baird
Geen lopende functies
Profiel
William Denise Baird is currently President & Chief Executive Officer at Poplar Therapeutics, Inc. since 2025 and Non-Executive Director at Deep Genomics, Inc. since 2026.
Former roles include President, Chief Executive Officer & Director at 2seventy Bio, Inc. from 2024 to 2025; Independent Director at Axcella Health, Inc. from 2018 to 2023; Director at Amicus Therapeutics UK Ltd.; Chief Financial Officer at Amicus Therapeutics, Inc. from 2012 to 2018; Chief Financial Officer at PTC Therapeutics, Inc. from 2005 to 2012; Chief Financial & Accounting Officer at Genetix Biotherapeutics, Inc. in 2021; and Engagement Manager at The Lek from 1999 to 2002.
Education includes an MBA from The Wharton School of the University of Pennsylvania and undergraduate studies at Edmund A. Walsh School of Foreign Service.
Actieve functies van Chip Baird
| Bedrijven | Functie | Begin |
|---|---|---|
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Directeur/Bestuurslid | 23-07-2026 |
Eerdere bekende functies van Chip Baird
| Bedrijven | Functie | Einde |
|---|---|---|
| 2SEVENTY BIO, INC. | Algemeen Directeur | 13-05-2025 |
| AXCA HEALPAR | Directeur/Bestuurslid | 01-11-2023 |
| GENETIX BIOTHERAPEUTICS, INC. | Financieel Directeur/CFO | 04-11-2021 |
| AMICUS THERAPEUTICS, INC. | Financieel Directeur/CFO | 19-12-2018 |
| PTC THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-04-2012 |
Opleiding van Chip Baird
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edmund A. Walsh School of Foreign Service
 Edmund A. Walsh School of Foreign Service Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Health Technology |
Amicus Therapeutics UK Ltd.
 Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
